MIND diet may shield breast cancer patients from 'Chemo Brain'

NCT ID NCT05984888

Recruiting now Symptom relief Sponsor: Ohio State University Comprehensive Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests whether a diet called MIND (rich in berries, leafy greens, and fish) can help protect memory and thinking in women with breast cancer who are starting chemotherapy. 43 postmenopausal women with stage II-IV breast cancer will receive either nutrition counseling on the MIND diet or general health advice. Researchers will measure cognitive function remotely over 12 weeks and again 6 months later.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MIND diet (a combination of brain-healthy foods like leafy greens, berries, nuts, and fish, while limiting unhealthy foods)
What this could lead to: If it works, this could point toward a simple dietary approach to reduce memory and thinking problems after chemotherapy.
What could go wrong: This is a very small pilot study (43 people) with no placebo control, so results may not be reliable or apply to everyone. The diet may be hard to follow during cancer treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Ohio State University Comprehensive Cancer Center
RECRUITING

Columbus, Ohio, 43210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.